RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients

Konrad Lewandowski; Katarzyna Karłowicz; Joanna Sarbinowska; Maciej Gonciarz; Dagmara Mahadea; Liliana Łykowska-Szuber; Piotr Eder; Anna Chaber-Ciopińska; Edyta Zagórowicz; Grażyna Rydzewska

doi:10.5114/pg.2026.159896

Streszczenie

1/2026 vol. 21

Artykuł oryginalny

RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients

Konrad Lewandowski ¹

,

Katarzyna Karłowicz ¹

,

Joanna Sarbinowska ²

,

Maciej Gonciarz ²

,

Dagmara Mahadea ³

,

Liliana Łykowska-Szuber ³

,

Piotr Eder ³

,

Anna Chaber-Ciopińska ^{4, 5}

,

Edyta Zagórowicz ^{4, 5}

,

Grażyna Rydzewska ^{1, 6}

Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
Department of Gastroenterology and Internal Medicine, Military Institute of Medicine – National Research Institute, Warsaw, Poland
Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University of Medical Sciences, H. Święcicki University Hospital, Poznan, Poland
Department of Oncological Gastroenterology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland
Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Gastroenterology Rev 2026; 21 (1): 38–44

DOI: https://doi.org/10.5114/pg.2026.159896

Data publikacji online: 2026/03/04

Pełna treść artykułu

AMA

Lewandowski K, Karłowicz K, Sarbinowska J, et al. RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review/Przegląd Gastroenterologiczny. 2026;21(1):38-44. doi:10.5114/pg.2026.159896.

APA

Lewandowski, K., Karłowicz, K., Sarbinowska, J., Gonciarz, M., Mahadea, D., & Łykowska-Szuber, L. et al. (2026). RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review/Przegląd Gastroenterologiczny, 21(1), 38-44. https://doi.org/10.5114/pg.2026.159896

Chicago

Lewandowski, Konrad, Katarzyna Karłowicz, Joanna Sarbinowska, Maciej Gonciarz, Dagmara Mahadea, Liliana Łykowska-Szuber, and Piotr Eder et al. 2026. "RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients". Gastroenterology Review/Przegląd Gastroenterologiczny 21 (1): 38-44. doi:10.5114/pg.2026.159896.

Harvard

Lewandowski, K., Karłowicz, K., Sarbinowska, J., Gonciarz, M., Mahadea, D., Łykowska-Szuber, L., Eder, P., Chaber-Ciopińska, A., Zagórowicz, E., and Rydzewska, G. (2026). RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review/Przegląd Gastroenterologiczny, 21(1), pp.38-44. https://doi.org/10.5114/pg.2026.159896

MLA

Lewandowski, Konrad et al. "RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 21, no. 1, 2026, pp. 38-44. doi:10.5114/pg.2026.159896.

Vancouver

Lewandowski K, Karłowicz K, Sarbinowska J, Gonciarz M, Mahadea D, Łykowska-Szuber L et al. RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients. Gastroenterology Review/Przegląd Gastroenterologiczny. 2026;21(1):38-44. doi:10.5114/pg.2026.159896.

Udostępnij

Dostępne w

Indeksowane w

Zintergrowane z

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications